3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
7
Pancreatic Neoplasms
6
Brain Neoplasms
6
Neoplasms
5
Glioma
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Liver Neoplasms
2
Glioblastoma
2
Disease
2
Central Nervous System Neoplasms
2
Astrocytoma
2
Urinary Bladder Neoplasms
1
Soft Tissue Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Penile Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Cyst
1
Osteosarcoma
1
Nervous System Diseases
1
Muscle Weakness
1
Metabolic Diseases
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Interventions
regorafenib
1
dinutuximab
1
Weight-Bearing
1
Surveys and Questionnaires
1
Standard of Care
1
Restraint, Physical
1
Range of Motion, Articular
1
Quality of Life
1
Quality Assurance, Health Care
1
Platinum
1
Observation
1
Metastasectomy
1
Masks
1
Magnetic Resonance Imaging
1
Genetic Testing
1
Gemcitabine
1
Doxorubicin
1
Data Collection
1
Cyclophosphamide
1
Cisplatin
1
Behavioral Sciences
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Bone Neoplasms
×
Magnetic Resonance Imaging
×
Clear all
NCT04394052
2020-07-21
TUMOSTEO II
Central Hospital, Nancy, France
Recruiting
740 enrolled